Cargando…
Discovery of a fragment hit compound targeting D-Ala:D-Ala ligase of bacterial peptidoglycan biosynthesis
Bacterial resistance is an increasing threat to healthcare systems, highlighting the need for discovering new antibacterial agents. An established technique, fragment-based drug discovery, was used to target a bacterial enzyme Ddl involved in the biosynthesis of peptidoglycan. We assembled general a...
Autores principales: | Proj, Matic, Hrast, Martina, Bajc, Gregor, Frlan, Rok, Meden, Anže, Butala, Matej, Gobec, Stanislav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718554/ https://www.ncbi.nlm.nih.gov/pubmed/36446617 http://dx.doi.org/10.1080/14756366.2022.2149745 |
Ejemplares similares
-
Inhibition of D-Ala:D-Ala ligase through a phosphorylated form of the antibiotic D-cycloserine
por: Batson, Sarah, et al.
Publicado: (2017) -
Fragment-Sized
Thiazoles in Fragment-Based Drug Discovery
Campaigns: Friend or Foe?
por: Proj, Matic, et al.
Publicado: (2022) -
Building Graphs To Describe Dynamics, Kinetics, and
Energetics in the d-ALa:d-Lac Ligase
VanA
por: Duclert-Savatier, Nathalie, et al.
Publicado: (2016) -
Production of Functional Buttermilk and Soymilk Using Pediococcus acidilactici BD16 (alaD(+))
por: Sharma, Anshula, et al.
Publicado: (2021) -
Mur ligase F as a new target for the flavonoids quercitrin, myricetin, and (–)-epicatechin
por: Rambaher, Martina Hrast, et al.
Publicado: (2023)